MedPath

Perindopril

Generic Name
Perindopril
Brand Names
Aceon, Coversyl, Prestalia, Viacoram
Drug Type
Small Molecule
Chemical Formula
C19H32N2O5
CAS Number
82834-16-0
Unique Ingredient Identifier
Y5GMK36KGY
Background

Perindopril is a nonsulfhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly metabolized in the liver to perindoprilat, its active metabolite, following oral administration. Perindoprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Perindopril may be used to treat mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease.

Indication

For the treatment of mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease.

Associated Conditions
Cardiovascular Events, Diabetic Nephropathy, Hypertension, Hypertension, Essential Hypertension, Myocardial Infarction, NYHA Class I Congestive heart failure, Stroke, Chronic heart failure with reduced ejection fraction (NYHA Class II), Chronic heart failure with reduced ejection fraction (NYHA Class III)

TOPSPIN Study Reveals Effective Single-Pill Combinations for Hypertension in South Asians

The TOPSPIN study, conducted by the Centre for Chronic Disease Control in collaboration with AIIMS and Imperial College London, has demonstrated the effectiveness of three double anti-hypertensive pill combinations in South Asian populations with uncontrolled hypertension. The study found that all three combinations were equally effective and safe, achieving blood pressure control in approximately 70% of participants. This research provides a significant advancement in hypertension management for South Asians, offering clinicians a roadmap for treatment.
© Copyright 2025. All Rights Reserved by MedPath